BeOne Medicines Ltd.·4

Jun 18, 5:19 PM ET

Lee Chan Henry 4

4 · BeOne Medicines Ltd. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

BeOne (ONC) SVP/General Counsel Lee Chan Henry Sells 590 Shares

What Happened Lee Chan Henry, SVP and General Counsel of BeOne Medicines (ONC), sold 590 American Depositary Shares (ADS) on June 16, 2026, at $265.98 per ADS for proceeds of $156,925. The filing indicates the sale was effected to satisfy tax withholding obligations related to the vesting of a previously granted restricted share unit (RSU) award — a routine, non-discretionary sale tied to vesting rather than a market-timed equity sale.

Key Details

  • Transaction date: 2026-06-16; Filing date (Form 4): 2026-06-18 (filed on time).
  • Price and size: 590 ADS at $265.98 each; reported proceeds $156,925.
  • ADS conversion: Each ADS represents 13 ordinary shares, so 590 ADS = 7,670 underlying ordinary shares.
  • Reason: Sale effected pursuant to mandatory tax withholding on RSU vesting (footnote). Vesting schedule: 1/4 of the award vests each anniversary of June 15, 2023; unvested securities may accelerate on certain termination events.
  • Transaction codes: Reported as a sale (S) with tax-withholding treatment per the footnote (F / tax withholding).
  • Shares owned after transaction: Not specified in the provided excerpt.

Context This was a tax-withholding sale to cover withholding liabilities when RSUs vested — a common administrative transaction that does not necessarily indicate insider sentiment. For retail investors, purchases by insiders are generally more indicative of conviction; tax-related sales are routine and often required by award agreements.

Insider Transaction Report

Form 4
Period: 2026-06-16
Lee Chan Henry
SVP, General Counsel
Transactions
  • Sale

    American Depositary Shares

    [F1][F2]
    2026-06-16$265.98/sh590$156,9250 total
Holdings
  • Ordinary Shares

    338,884
Footnotes (2)
  • [F1]Each American Depositary Share represents 13 Ordinary Shares.
  • [F2]The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Signature
/s/ Qing Nian, as Attorney-in-Fact|2026-06-18

Documents

1 file
  • 4
    wk-form4_1781817574.xmlPrimary

    FORM 4